scispace - formally typeset
A

Alessandro Giacomello

Researcher at Sapienza University of Rome

Publications -  76
Citations -  4854

Alessandro Giacomello is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Stem cell & Hypoxanthine. The author has an hindex of 22, co-authored 75 publications receiving 4524 citations.

Papers
More filters
Journal ArticleDOI

Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart

TL;DR: The isolation of undifferentiated cells that grow as self-adherent clusters (that are termed “cardiospheres”) from subcultures of postnatal atrial or ventricular human biopsy specimens and from murine hearts are described.
Journal ArticleDOI

Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens

TL;DR: Cardiogenic CDCs are cardiogenic in vitro; they promote cardiac regeneration and improve heart function in a mouse infarct model, which provides motivation for further development for therapeutic applications in patients.
Journal ArticleDOI

Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice

TL;DR: Together with their spontaneous commitment to cardiac and angiogenic differentiation, transplanted CDCs serve as “role models,” recruiting endogenous regeneration and improving tissue resistance to ischemic stress.
Journal ArticleDOI

Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction.

TL;DR: An effective and translational approach is developed to enhance hCMPC delivery and action in the heart by evaluating the therapeutic potential of a 3D-printed patch composed of human cardiac-derived progenitor cells in a hyaluronic acid/gelatin (HA/gel) based matrix.
Journal ArticleDOI

Cardiac stem cells: Isolation, expansion and experimental use for myocardial regeneration

TL;DR: Cardiac stem cells represent a logical source to exploit in cardiac regeneration therapy because, unlike other adult stem cells, they are likely to be intrinsically programmed to generate cardiac tissue in vitro and to increase cardiac tissue viability in vitro.